Therapeutic Approaches to the Alternative Angiotensin-(1-7) Axis of the Renin-Angiotensin System

Overview

Journal Ann Pharmacol Pharm

Date 2023 Jan 16

PMID 36643780

Authors

Mark C Chappell

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease remains the leading cause of death for both men and women in the United States despite the recent advances in drug development, changes in lifestyle and screening protocols. A key target in the treatment of cardiovascular disease and hypertension is the renin-angiotensinsystem (RAS), a circulating and tissue system involved in the regulation of blood pressure, fluid balance and cellular injury. Pharmacologic approaches have traditionally focused on the Ang II-AT1receptor axis of the RAS to prevent the generation of Ang II with angiotensin converting enzyme inhibitors (ACEI) or to block the binding of Ang II to the AT1 receptor (AT1R) with selective antagonists (ARBs).

Citing Articles

The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury.

Villapol S, Janatpour Z, Affram K, Symes A Neurotherapeutics. 2023; 20(6):1565-1591.

PMID: 37759139 PMC: 10684482. DOI: 10.1007/s13311-023-01435-8.

References

Wester A, Devocelle M, Tallant E, Chappell M, Gallagher P, Paradisi F . Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid. Amino Acids. 2017; 49(10):1733-1742. PMC: 9239115. DOI: 10.1007/s00726-017-2471-9. View

Chappell M, Brosnihan K, Diz D, Ferrario C . Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides. J Biol Chem. 1989; 264(28):16518-23. View

Yousif M, Benter I, Diz D, Chappell M . Angiotensin-(1-7)-dependent vasorelaxation of the renal artery exhibits unique angiotensin and bradykinin receptor selectivity. Peptides. 2017; 90:10-16. PMC: 6688182. DOI: 10.1016/j.peptides.2017.02.001. View

Leonhardt J, Villela D, Teichmann A, Munter L, Mayer M, Mardahl M . Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MAS. Hypertension. 2017; 69(6):1128-1135. DOI: 10.1161/HYPERTENSIONAHA.116.08814. View

Santos R . Angiotensin-(1-7). Hypertension. 2014; 63(6):1138-47. DOI: 10.1161/HYPERTENSIONAHA.113.01274. View

A Crackower M, Sarao R, Oudit G, Yagil C, Kozieradzki I, Scanga S . Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002; 417(6891):822-8. DOI: 10.1038/nature00786. View

Garabelli P, Modrall J, Penninger J, Ferrario C, Chappell M . Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart. Exp Physiol. 2008; 93(5):613-21. PMC: 2675708. DOI: 10.1113/expphysiol.2007.040246. View

Ellis B, Li X, Miguel-Qin E, Gu V, Zhuo J . Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney. Am J Physiol Regul Integr Comp Physiol. 2011; 302(5):R494-509. PMC: 3833928. DOI: 10.1152/ajpregu.00487.2011. View

Nagata S, Kato J, Sasaki K, Minamino N, Eto T, Kitamura K . Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system. Biochem Biophys Res Commun. 2006; 350(4):1026-31. DOI: 10.1016/j.bbrc.2006.09.146. View

10.

Shenoy V, Ferreira A, Qi Y, Fraga-Silva R, Diez-Freire C, Dooies A . The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med. 2010; 182(8):1065-72. PMC: 2970847. DOI: 10.1164/rccm.200912-1840OC. View

11.

Qi Y, Zhang J, Cole-Jeffrey C, Shenoy V, Espejo A, Hanna M . Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension. 2013; 62(4):746-52. PMC: 3881360. DOI: 10.1161/HYPERTENSIONAHA.113.01337. View

12.

Poglitsch M, Domenig O, Schwager C, Stranner S, Peball B, Janzek E . Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System. Int J Hypertens. 2012; 2012:428950. PMC: 3299299. DOI: 10.1155/2012/428950. View

13.

Velkoska E, Dean R, Burchill L, Levidiotis V, Burrell L . Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition. Clin Sci (Lond). 2009; 118(4):269-79. PMC: 2782317. DOI: 10.1042/CS20090318. View

14.

Lautner R, Villela D, Fraga-Silva R, Silva N, Verano-Braga T, Costa-Fraga F . Discovery and characterization of alamandine: a novel component of the renin-angiotensin system. Circ Res. 2013; 112(8):1104-11. DOI: 10.1161/CIRCRESAHA.113.301077. View

15.

Gwathmey T, Alzayadneh E, Pendergrass K, Chappell M . Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol. 2011; 302(5):R518-30. PMC: 3311515. DOI: 10.1152/ajpregu.00525.2011. View

16.

Wilson B, Cruz-Diaz N, Marshall A, Pirro N, Su Y, Gwathmey T . An angiotensin-(1-7) peptidase in the kidney cortex, proximal tubules, and human HK-2 epithelial cells that is distinct from insulin-degrading enzyme. Am J Physiol Renal Physiol. 2015; 308(6):F594-601. PMC: 4360035. DOI: 10.1152/ajprenal.00609.2014. View

17.

Cruz-Diaz N, Wilson B, Pirro N, Brosnihan K, Marshall A, Chappell M . Identification of dipeptidyl peptidase 3 as the Angiotensin-(1-7) degrading peptidase in human HK-2 renal epithelial cells. Peptides. 2016; 83:29-37. PMC: 5500233. DOI: 10.1016/j.peptides.2016.06.005. View

18.

Wysocki J, Ye M, Khattab A, Fogo A, Martin A, David N . Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy. Kidney Int. 2016; 91(6):1336-1346. PMC: 5429993. DOI: 10.1016/j.kint.2016.09.032. View

19.

Oudit G, Liu G, Zhong J, Basu R, Chow F, Zhou J . Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes. 2009; 59(2):529-38. PMC: 2809962. DOI: 10.2337/db09-1218. View

20.

De Maria M, Araujo L, Fraga-Silva R, Pereira L, Ribeiro H, Menezes G . Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats. Protein Pept Lett. 2015; 23(1):9-16. DOI: 10.2174/0929866522666151013130550. View